Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Exp Neurol. 2014 Oct 23;270:88–94. doi: 10.1016/j.expneurol.2014.10.008

Figure 4. Fluoxetine prevents Ca2+ overload of NMJs in mSCS.

Figure 4

Left. Serial TA muscle sections labeled for cholinesterase (dark brown) to localize endplates and GBHA (red) to localize Ca2+ overloading in WT and mSCS. Ca2+ overloading was found at endplates of mSCS, but not in wild type (WT). Scale bar=60µm. Middle. Quantitation of Ca2+-overload of endplates (% GBHA-labeled endplates) in WT and in untreated mSCS mice (εL269F) and) with treatment of serial concentrations of fluoxetine. Endplates from WT TA showed no Ca2+-labeled endplates, while a significant number of NMJ were overloaded with Ca2+ in untreated εL269F (37.3±5.7%) and control εL269F treated with saline (mSCS (εL269F)-saline; 38.2±2.6%) whereas Ca2+-overloaded endplates were significantly decreased in 7.2 µg/g (15.8±2.3%) and 9.6 µg/g (11.9±4.2%) treatment. Right. The similar results were also shown in mSCS mice (δS268F). Compared with δS268F (44.7±0.5%) and control δS268F (44.3±2.7%), treated δS268F with a dose of 7.2 and 9.6 µg/g reduced Ca2+-labeled endplates to 17.4±0.8% and 6.1±1.7%, respectively. n=5–7; ***p<0.001. All comparisons were analyzed by Student’s t-test.